MedTrace Logo

VR to Reduce Pain and Anxiety During GU Scans

NCT04251988 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 410

Last updated 2023-06-15

No results posted yet for this study

Summary

This study aims to test the effectiveness of virtual reality (VR) in reducing pain and anxiety in children undergoing voiding cystourethrograms (VCUG) at Children's Hospital Los Angeles (CHLA). A voiding cystourethrogram is a genitourinary diagnostic scan that provides important urological information, specifically the filling and releasing of the bladder. This information can help diagnose urological issues in children. However, this procedure requires catheterization, which is understood to be a painful and anxiety-provoking procedure. This study will test the effectiveness of VR as a non-pharmaceutical intervention to relieve pain and anxiety in pediatric patients undergoing VCUGs.

Conditions

  • Urologic Diseases
  • Urogenital Disease
  • Vesico-Ureteral Reflux

Interventions

DEVICE

Oculus Go VR

virtual reality headset

Sponsors & Collaborators

Principal Investigators

  • Andy M Chang, MD · Children's Hospital Los Angeles

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
5 Years
Max Age
21 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-02-15
Primary Completion
2023-12-31
Completion
2023-12-31
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04251988 on ClinicalTrials.gov